K. Baker

Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints

S. Melgar, P. Cotter, C. Walsh, 2022, British Journal of Cancer.

Transcriptomic and functional analyses reveal a tumour-promoting role for the IL-36 receptor in colon cancer and crosstalk between IL-36 signalling and the IL-17/ IL-23 axis

E. Brint, A. Houston, K. Baker, 2022, British Journal of Cancer.

RNA polymerase and transcription elongation factor Spt4/5 complex structure

K. Murakami, D. Bose, Xiaodong Zhang, 2010, Proceedings of the National Academy of Sciences.

IL-1 Family Members in Cancer; Two Sides to Every Story

E. Brint, A. Houston, K. Baker, 2019, Front. Immunol..

IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore

E. Brint, A. Houston, Kevin J. Baker, 2021, Cellular and Molecular Life Sciences.

Malaria Consortium ’ s seasonal malaria chemoprevention program : Philanthropy report 2020

A. Roca-Feltrer, S. Richardson, Jamie Power, 2021 .

IL-36 expression is increased in NSCLC with IL-36 stimulation of lung cancer cells promoting a pro-tumorigenic phenotype.

E. Brint, L. Burke, A. Houston, 2023, Cytokine.

IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist

M. O'riordain, E. Brint, S. Keogh, 2022, Oncogene.